The microcapsule market is projected to grow at a CAGR of 9.8% from 2020 to 2025, in terms of value.
The microcapsule market is projected to grow from USD 8.7 billion in 2020 to USD 13.9 billion by 2025, at a CAGR of 9.8% from 2020 to 2025. The major reasons for the growth of the microcapsule market include increasing demand from the food industry, high demand from the pharmaceutical industry, rising demand from the agrochemical sector, increased R&D activities for process efficiency to enhance market penetration, and widespread applications of microcapsules
The melamine segment is estimated to lead the microcapsule market in terms of value from 2020 to 2025. By shell material, the melamine segment is projected to grow with the highest CAGR during the forecast period.The growth of the melamine segment is attributed to the increasing demand for formaldehyde-free melamine in personal care products.
Additionally, melamine shell materials offer excellent retention capacity for volatile molecules and tunable mechanical properties that make these melamine capsules highly suitable as a formaldehyde-free alternative to conventional aminoplast microcapsules. These factors have resulted in the growth in demand for melamine shell materials in microcapsule market.
Pharmaceutical & Healthcare Drugs accounted for the largest share of the microcapsule market, by source.
By core material, the pharmaceutical & healthcare drugs segment accounted for the largest share of the microcapsule market in 2019.The increasing demand for the masking of oral drug flavors to drive the growth of the pharmaceutical & healthcare drugs segment.
Also, Intensive marketing by key players and increased applications of nutritional elements in functional and fortified foods drive the demand for pharmaceutical & healthcare drugs.
Pharmaceutical & Healthcare accounted for the largest share of the microcapsule market, by source.
By end-use industry, the pharmaceutical & healthcare segment accounted for the largest share of the microcapsule market in 2019. Factors like controlled release of drugs, timely delivery of functional ingredients, and taste masking properties of microcapsules drives the growth of the microcapsule market in the pharmaceutical & healthcare end-use industry segment.
Dripping Technologies segment is estimated to lead the microcapsule market in terms of value from 2020 to 2025. By technology, the dripping technologies segment is projected to grow with the highest CAGR during the forecast period.Dripping technologies include droplet extrusion through spinning disks, jet breakage systems, and coextrusion.
These technologies are applied for liquid, solid, hydrophilic, and lipophilic materials.The major advantages of dripping technologies are biocompatibility and low particle size distribution, which is expected to drive the growth for dripping technologies.
Also, growing demand for microencapsulated active ingredients in pharmaceutical industry to drive market growth for dripping technologies.
North America is projected to lead the microcapsule market during the forecast period, in terms of value.
The North American region is projected to lead the microcapsule market from 2020 to 2025 in terms of value. The microcapsule market in North America is majorly driven by the growing demand and consumer awareness about value-added products in various areas, such as nutrition, food, healthcare, and personal care.
Profile break-up of primary participants for the report: • By Company Type: Tier 1 – 65%, Tier 2 – 20%, and Tier 3 – 15% • By Designation: C-level Executives – 25%, Directors – 30%, and Others – 45% • By Region: North America – 30%, Europe – 20%, Asia Pacific – 40%, South America – 3%, Middle East & Africa – 7%,
As a part of qualitative analysis, the research provides a comprehensive review of market drivers, restraints, opportunities, and challenges. It also discusses competitive strategies adopted by varied market players, such as BASF SE (Germany), International Flavors & Fragrances (US), Koninklijke DSM N.V. (Netherlands), Symrise AG (Germany), Givaudan S.A. (Switzerland), Sensient Technologies Corporation (US), Royal FrieslandCampina N.V. (Netherlands), Syngenta Crop Protection AG (Switzerland), Lycored Corp. (Israel), Koehler Innovative Solutions (Germany), Balchem Corporation (US), Capsulæ SAS (France), TasteTech Ltd. (UK), MicroCapsules Technologies (MCT) (France), INSILICO Co. Ltd. (South Korea), Matsumoto Yushi Seiyaku Co., Ltd. (Japan), Encapsys (US), Arcade Beauty (US), Reed Pacific (Australia), Firmenich SA (Switzerland), Ronald T. Dodge Company (US), Microtek Laboratories, Inc. (US), AVEKA, Inc. (US), INNOBIO (China), GAT Microencapsulation GmbH (Austria), BRACE GmbH (Germany), and Tagra Biotechnologies Ltd. (Israel).
Research Coverage: The report defines, segments, and projects the microcapsule market based on shell material, core material, end-use industry, technology, and region.It provides detailed information regarding the major factors influencing the growth of the market, such as drivers, restraints, opportunities, and industry-specific challenges.
It strategically profiles key players and comprehensively analyzes their market shares and core competencies as well as tracks and analyzes competitive developments, such as expansions, acquisitions, new product launches, and partnerships undertaken by them in the market.
Reasons to Buy the Report: The report is expected to help the market leaders/new entrants in the market by providing them the closest approximations of revenue numbers of the microcapsule market and its segments.This report is also expected to help stakeholders obtain an improved understanding of the competitive landscape of the market, gain insights to improve the position of their businesses, and make suitable go-to-market strategies.
It also enables stakeholders to understand the pulse of the market and provide them information on key market drivers, restraints, challenges, and opportunities.
Our reports have been used by over 10K customers, including:
The global life science analytics market size is projected to reach USD 42.0 billion by 2025 from USD 22.1 billion in 2020, at a CAGR of 13.7% during the forecast period. Growth in this market is mainly driven by technological advancements, big data in the life science industry, growing adoption of analytics solutions in clinical trials, increasing...
Industrial safety market to exhibit significant growth during 2020–2025 The global industrial safety market is estimated to grow from from USD 5.6 billion in 2020 to USD 7.7 billion by 2025, at a CAGR of 6.7%. The adoption of standards such as IEC 61508 and IEC 61511 has led to increased dependency on industrial safety systems to attain...
The global anti - viral therapies market is expected to reach US$ 76,282.63 million by 2027 from US$ 40,589.79 million in 2019; it is estimated to grow at a CAGR of 8.3% from 2020 to 2027. The growth of the anti - viral therapies market is mainly attributed to the increasing R&D expenditures by pharmaceutical companies, and rising government...
In terms of revenue, the global Cold Chain market was valued at US$ 207,510.8 million in 2019 and is projected to reach US$ 398,723.4 million by 2027 and is expected to grow at a CAGR of 10.8% during the forecast period. At present, with a rapid modernization, there is increase in purchase of perishable food items from marts and retail...
The North America starch softgel capsules market is expected to reach US$ 202.54 million by 2027 from US$ 139.13 million in 2019. The market is estimated to grow at a CAGR of 4.9% from 2020 to 2027. The growth of the North America starch softgel capsules market is attributed to increasing availability of vegetarian softgel capsules and...
Equine Pharmaceuticals & Supplements Market Research Report by Product (Pharmaceutical and Supplement), by Distribution Channel (Drug Stores and Veterinary Hospitals) - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Equine Pharmaceuticals & Supplements Market is expected to grow from USD 757.54 Million...
Human Cytomegalovirus Envelope Glycoprotein B - Pipeline Review, H2 2020 Summary Human Cytomegalovirus Envelope Glycoprotein B (gB) - Human Cytomegalovirus envelope glycoprotein B plays an important role in host cell entry and cell to cell virus transmission. It is involved in the initial attachment...
Osteomyelitis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Osteomyelitis - Pipeline Review, H2 2020, provides an overview of the Osteomyelitis (Infectious Disease) pipeline landscape. Osteomyelitis is an infection in a bone. Infections...
Bromodomain Containing Protein 4 - Pipeline Review, H2 2020 Summary Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Bromodomain-containing protein 4 is a protein encoded by the BRD4 gene. It plays a key role in transmission of epigenetic memory across cell divisions and transcription regulation....
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.